Ability of azithromycin in combination with quinine for the elimination of babesial infection in humans

American Journal of Tropical Medicine and Hygiene

Volumn 59, Issue 4, 1998, Pages 509-512

  Shih, Chien Ming ^a   Wang, Chih Chien ^b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLINDAMYCIN; QUININE;

ADULT; ARTICLE; BABESIOSIS; BLOOD EXAMINATION; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DRUG EFFICACY; FEMALE; HUMAN; INOCULATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PARASITE ISOLATION; SERODIAGNOSIS;

BABESIA; CINCHONA PUBESCENS; CRICETINAE; PROTOZOA;

EID: 0031783682     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1998.59.509     Document Type: Article

References (30)

1. Telford III SR, Gorenflot A, Brasseur P, Spielman A, 1993. Babesial infections in man and wildlife. Kreier JP, ed. Parasitic Protozoa. Second edition. Volume 5. New York, Academic Press, Inc., 1-47.
2. Spielman A, 1976. Human babesiosis on Nantucket Island: transmission by nymphal Ixodes ticks. Am J Trop Med Hyg 25: 784-787.
3. Spielman A, Wilson ML, Levine JF, Piesman J, 1985. Ecology of Ixodes dammini-borne human babesiosis and Lyme disease. Annu Rev Entomol 30: 439-460.
4. Marcus LC, Valigorsky JM, Fanning WL, Joseph T, Glick B, 1982. A case report of transfusion-induced babesiosis. JAMA 248: 465-468.
5. Grabowski EF, Giardina PJV, Goldberg D, Masur H, Read SE, Hirsch RL, Benach JL, 1982. Babesiosis transmitted by a transfusion of frozen-thawed blood. Ann Intern Med 96: 466-467.
6. Herwaldt BL, Kjemtrup AM, Conrad PA, Barnes RC, Wilson M, McCarthy MG, Sayers MH, Eberhard ML, 1997. Transfusion-transmitted babesiosis in Washington State: first reported case caused by a WA1-type parasite. J Infect Dis 175: 1259-1262.
7. Garnham PCC, 1980. Human babesiosis: European aspects. Trans R Soc Trop Med Hyg 74: 153-155.
8. Meldrum SC, Birkhead GS, White DJ, Benach JL, Morse DL, 1992. Human babesiosis in New York state: an epidemiological description of 136 cases. Clin Infect Dis 15: 1019-1023.
9. Sim JG, Park HS, Ahn DH, 1988. A case of babesiosis in an eight year old Korean boy. Korean J Intern Med 35: 1417-1421.
10. Shin CM, Liu LP, Chung WC, Ong SJ, Wang CC, 1997. Human babesiosis in Taiwan: asymptomatic infection with Babesia microti-like organism in a Taiwanese woman. J Clin Microbiol 35: 450-454.
11. Wittner M, Rowin K, Tanowitz H, Hobbs JF, Saltzman S, Wenz B, Hirsch R, Chisholm E, Healy GR, 1982. Successful chemotherapy of transfusion babesiosis. Ann Intern Med 96: 601-604.
12. Rowin KS, Tanowitz HB, Wittner M, 1982. Therapy of experimental babesiosis. Ann Intern Med 97: 556-558.
13. Dammin GJ, Spielman A, Mahoney EB, Bracker EF, Kaplan K, 1983. Clindamycin and quinine treatment for Babesia microti infections. MMWR Morb Mortal Wkly Rep 32: 65-72.
14. Benezra D, Brown AE, Polsky B, Gold JW, Armstrong D, 1987. Babesiosis and infection with human immunodeficiency virus (HIV) (letter). Ann Intern Med 107: 944.
15. Ong KR, Stavropoulos C, Inada Y, 1990. Babesiosis, asplenia, and AIDS (letter). Lancet 336: 112.
16. Falagas ME, Klempner MS, 1996. Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin. Clin Infect Dis 22: 809-812.
17. Miller LH, Neva FA, Gill F, 1978. Failure of chloroquine in human babesiosis (Babesia microti).Ann Intern Med 88: 200-202.
18. Araujo FG, Guptill DR, Remington JS, 1988. Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii.Antimicrob Agents Chemother 32: 755-757.
19. Ravdin JI, Skilogiannis J, 1989. In vitro susceptibilities of Entomoeba histolytica to azithromycin, CP-63956, erythromycin, and metronidazole. Antimicrob Agents Chemother 33: 960-962.
20. Crouch AA, Seow WK, Whitman LM, Thong YH. 1990. Sensitivity in vitro of Giardia intestinalis to dyadic combinations of azithromycin, doxycycline, mefloquine, tinidazole, and furazolidone.Trans R Soc Trop Med Hyg 84: 246-248.
21. Weiss LM, Wittner M, Wasserman S, Oz HS, Retsema J, Tanowitz HB, 1993. Efficacy of azithromycin for treating Babesia microti infection in the hamster model. J Infect Dis 168: 1289-1292.
22. Anderson SL, Ager AL, McGreevy R Schuster BG, Ellis W, Berman J, 1994. Efficacy of azithromycin as a causal prophylactic agent against murine malaria. Antimicrob Agents Chemother 38: 1862-1863.
23. Anderson SL, Ager AL, McGreevy P, Schuster BG, Wesche D, Kuschner R, Ohrt C, Ellis W, Rossan R, Berman J, 1995. Activity of azithromycin as a blood schizonticide against rodent and human plasmodia in vivo. Am J Trop Med Hyg 52: 159-161.
24. Anderson SL, Berman J, Kuschner R, Wesche D, Magill A, Wellde B, Schneider I, Dunne M, Schuster BG, 1995. Prophylaxis of Plasmodium falciparum malaria with azithromycin administered to volunteers. Ann Intern Med 123: 771-773.
25. Mehlhorn H, Schein E, 1984. The piroplasms: life cycle and sexual stages. Adv Parasitol 23: 37-103.
26. Phillips RS, 1969. The role of the spleen in relation to natural and acquired immunity to infections of Babesia rodhaini in the rat. Parasitology 59: 637-648.
27. Clark IA, Allison AC, 1974. Babesia microti and Plasmodium berghei yoelii infections in nude mice. Nature 252: 328-329.
28. Girard AE, Girard D, English AR, Gootz TD, Cimochowski CR, Faiella JA, Haskell SL, Retsema JA, 1987. Pharmacokinetic and in vivo studies with azithromycin (CP-62993), a new macrolide with an extended half-life and excellent tissue penetration. Antimicrob Agents Chemother 31: 1948-1954.
29. Gladue RP, Bright GM, Isaacson RE, Newborg MF, 1989. In vitro and in vivo uptake of azithromycin (CP-62993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob Agents Chemother 33: 277-282.
30. Schentag JJ, Ballow CH, 1991. Tissue-directed pharmacokinetics. Am J Med 91 (suppl 3A): 5S-11S.